Abstract
Protein Kinase C (PKC) is a serine/threonine kinase that involved in controlling of many cellular processes such as cell proliferation and differentiation. We have observed previously that TPA (12-O-tetradecanoylphorbol 13-acetate) induces cell cycle arrest in G0/G1 phase in human hepatoma HepG2 cells. However, is there any miRNA involved in PKCalpha mediated cell growth arrest is still unknown. We first surveyed 270 miRNA expression profiles in 20 pairs of human hepatoma tissues. We identified 11 up-regulated and 23 down-regulated miRNAs (FDR < = 0.01; fold-change > = 2) in human hepatoma tissue after Student's T-test and Mann-Whitney rank test. We then examined miRNAs expression profile in TPA treated HepG2 cells. Two miRNAs, miR-101, and miR-29c, were shown to be significantly down regulated in human hepatoma tissues and induced over 4-fold in HepG2 cells under TPA treatment. In this study, we examined TPA regulated miRNA expression profile in human hepatoma HepG2 cells. We identified two miRNAs, 101 and 29c, were induced by TPA and down regulated in human hepatoma tissues suggest that they might play as tumor suppressor gene and in tumor formation of HCC. Since induction kinetics of miR-101 by TPA was much faster than miR-29c suggests that the induction of miR-101 may be the primary response of TPA treatment. We then further investigated how miR-101 was regulated by TPA. MiR-101 targets two subunits of PRC2 complex, enhancer of zeste homolog 2 (EZH2) and EED, and was shown to play as a tumor suppressor gene in human prostate, breast and liver cancers. The target sequence of miR-101 located in the 3' UTR of both EZH2 and EED's mRNA was identified by bioinformatic analysis and was validated by reporter luciferase activity assay. Then we showed that TPA not only up regulated miR-101 expression, but also reduced protein level of EZH2, EED and H3K27me3 in HepG2 cells. Using lenti-virus-mediated shRNA to knockdown endogenous PKCalpha expression, we observed that TPA induced growth arrest, elevation of miR-101 and reduction of EZH2, EED and H3K27me3 proteins were all PKCalpha dependent. Specific inhibitor of ERK completely blocked TPA induced miR-101 expression. Therefore, this is the first time to show that PKCalpha and ERK pathway play important role to activate miR-101 expression, reduce PRC2 complex and H3K27me3 level. This epigenetic regulatory pathway may represent a novel mechanism of carcinogenesis and deserve further investigation.
MeSH Terms
3' Untranslated Regions
Base Sequence
Carcinoma, Hepatocellular/genetics,metabolism
Cell Cycle/drug effects,genetics,physiology
Cell Line, Tumor
DNA Primers/genetics
DNA-Binding Proteins/genetics
Enhancer of Zeste Homolog 2 Protein
Female
Gene Expression Profiling
Humans
Kinetics
Liver Neoplasms/genetics,metabolism
MAP Kinase Signaling System/drug effects,genetics,physiology
Male
MicroRNAs/biosynthesis,genetics
Polycomb Repressive Complex 2
Protein Kinase C-alpha/antagonists & inhibitors,genetics,metabolism
RNA, Small Interfering/genetics
Repressor Proteins/genetics
Tetradecanoylphorbol Acetate/pharmacology
Transcription Factors/genetics
Chemicals
3' Untranslated Regions
DNA Primers
DNA-Binding Proteins
EED protein, human
MIRN101 microRNA, human
MIRN29a microRNA, human
MicroRNAs
RNA, Small Interfering
Repressor Proteins
Transcription Factors
EZH2 protein, human
Enhancer of Zeste Homolog 2 Protein
Polycomb Repressive Complex 2
Protein Kinase C-alpha
Tetradecanoylphorbol Acetate
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Chiang Chao-Wei
Institute of Microbiology & Immunology, National Yang-Ming University, Taipei, Taiwan.
Huang Yi
Leong Ka-Wai
Chen Lih-Chyang
Chen Hua-Chien
Chen Shu-Jen
Chou Chen-Kung
References (29)
29 references, click to expand
-
Protein kinase C alpha trigger Ras and Raf-independent MEK/ERK activation for TPA-induced growth inhibition of human hepatoma cell HepG2.
Cancer Lett. 2006 Jul 28;239(1):27-35
PMID: 16169661
-
Transfecting mammalian cells: optimization of critical parameters affecting calcium-phosphate precipitate formation.
Nucleic Acids Res. 1996 Feb 15;24(4):596-601
PMID: 8604299
-
miRNPs: a novel class of ribonucleoproteins containing numerous microRNAs.
Genes Dev. 2002 Mar 15;16(6):720-8
PMID: 11914277
-
MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins.
Proc Natl Acad Sci U S A. 2008 Apr 15;105(15):5874-8
PMID: 18390668
-
Cell-cycle control of microRNA-mediated translation regulation.
Cell Cycle. 2008 Jun 1;7(11):1545-9
PMID: 18469529
-
Inhibition of PC12 cell redox activity is a specific, early indicator of the mechanism of beta-amyloid-mediated cell death.
Proc Natl Acad Sci U S A. 1994 Feb 15;91(4):1470-4
PMID: 8108433
-
Activation of protein kinase C isozymes is associated with post-mitotic events in intestinal epithelial cells in situ.
J Cell Biol. 1994 Aug;126(3):747-63
PMID: 8045938
-
A microRNA expression signature of human solid tumors defines cancer gene targets.
Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2257-61
PMID: 16461460
-
Members of the miR-290 cluster modulate in vitro differentiation of mouse embryonic stem cells.
Differentiation. 2009 Sep-Oct;78(2-3):69-78
PMID: 19628328
-
A skin microRNA promotes differentiation by repressing 'stemness'.
Nature. 2008 Mar 13;452(7184):225-9
PMID: 18311128
-
Snail associates with EGR-1 and SP-1 to upregulate transcriptional activation of p15INK4b.
FEBS J. 2010 Mar;277(5):1202-18
PMID: 20121949
-
miR-34a, miR-29c and miR-17-5p are downregulated in CLL patients with TP53 abnormalities.
Leukemia. 2009 Jun;23(6):1159-63
PMID: 19158830
-
MicroRNA-101 regulates expression of the v-fos FBJ murine osteosarcoma viral oncogene homolog (FOS) oncogene in human hepatocellular carcinoma.
Hepatology. 2009 Apr;49(4):1194-202
PMID: 19133651
-
MicroRNAs: genomics, biogenesis, mechanism, and function.
Cell. 2004 Jan 23;116(2):281-97
PMID: 14744438
-
Protein kinase C isotypes and their specific functions: prologue.
J Biochem. 2002 Oct;132(4):509-11
PMID: 12359062
-
PKCdelta acts as a growth and tumor suppressor in rat colonic epithelial cells.
Oncogene. 1999 Feb 4;18(5):1251-6
PMID: 10022132
-
Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer.
Science. 2008 Dec 12;322(5908):1695-9
PMID: 19008416
-
MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias.
Proc Natl Acad Sci U S A. 2004 Aug 10;101(32):11755-60
PMID: 15284443
-
The transcriptional factor Snail simultaneously triggers cell cycle arrest and migration of human hepatoma HepG2.
J Biomed Sci. 2008 May;15(3):343-55
PMID: 18183498
-
MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B.
Proc Natl Acad Sci U S A. 2007 Oct 2;104(40):15805-10
PMID: 17890317
-
The putative tumor suppressor microRNA-101 modulates the cancer epigenome by repressing the polycomb group protein EZH2.
Cancer Res. 2009 Mar 15;69(6):2623-9
PMID: 19258506
-
Real-time quantification of microRNAs by stem-loop RT-PCR.
Nucleic Acids Res. 2005 Nov 27;33(20):e179
PMID: 16314309
-
Protein kinase C--a question of specificity.
Trends Biochem Sci. 1994 Feb;19(2):73-7
PMID: 8160269
-
Activation of protein kinase C alpha is required for TPA-triggered ERK (MAPK) signaling and growth inhibition of human hepatoma cell HepG2.
J Biomed Sci. 2005;12(2):289-96
PMID: 15917995
-
Protein kinase C-dependent upregulation of miR-203 induces the differentiation of human keratinocytes.
J Invest Dermatol. 2010 Jan;130(1):124-34
PMID: 19759552
-
MicroRNA deregulation and pathway alterations in nasopharyngeal carcinoma.
Br J Cancer. 2009 Mar 24;100(6):1002-11
PMID: 19293812
-
MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity.
Cancer Res. 2009 Feb 1;69(3):1135-42
PMID: 19155302
-
Causes and consequences of microRNA dysregulation in cancer.
Nat Rev Genet. 2009 Oct;10(10):704-14
PMID: 19763153
-
The extended protein kinase C superfamily.
Biochem J. 1998 Jun 1;332 ( Pt 2):281-92
PMID: 9601053